acetylcarnitine has been researched along with angiotensin ii in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benigni, A; Buelli, S; Cassis, P; Longaretti, L; Macconi, D; Morigi, M; Perico, L; Perico, N; Remuzzi, G | 1 |
| Hao, J; Shao, J; Wang, S; Xu, J; Zhang, X; Zhao, L; Zheng, J | 1 |
2 other study(ies) available for acetylcarnitine and angiotensin ii
| Article | Year |
|---|---|
Sirtuin3 Dysfunction Is the Key Determinant of Skeletal Muscle Insulin Resistance by Angiotensin II.
Topics: Acetylcarnitine; Angiotensin II; Animals; Cell Line; Insulin Resistance; Mitochondria; Muscle, Skeletal; Rats; Reactive Oxygen Species; Sirtuin 3 | 2015 |
Anti-Inflammatory and Antioxidant Effects of Acetyl-L-Carnitine on Atherosclerotic Rats.
Topics: Acetylcarnitine; Adiponectin; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Aorta; Atherosclerosis; Biomarkers; C-Reactive Protein; Inflammation Mediators; Interleukin-1beta; Lipids; Male; Myocardium; Nitric Oxide Synthase Type II; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger; Tumor Necrosis Factor-alpha | 2020 |